Skip to content

Insights

FDA & FTC compliance insights for healthcare marketing

Plain-English breakdowns of the warning letters, settlements, and regulatory shifts that determine whether your marketing can survive contact with a regulator.

Page 3 of 9

Specialty playbook

NAD+ Marketing Compliance: Why the FTC Has Your Clinic's Longevity Claims in Its Crosshairs

'Reverses aging,' 'extends lifespan,' 'restores cellular function' - the claims driving NAD+ marketing are the exact claims the FTC is currently pursuing. Here's the full compliance playbook for NAD+ IV, NAD+ injection, and NAD+ protocol marketing.

10 min
Read
Platform playbook

Meta Ads for Healthcare Practices: The Policy Layer on Top of FDA/FTC Rules

Your Meta ads must meet FDA rules, FTC rules, AND Meta's own healthcare advertising policy - three layers, not one. Here's the full playbook for what Meta actually enforces, how to avoid account-level issues, and how to structure ads that run reliably.

10 min
Read
Platform playbook

Google Ads for Healthcare Practices: Policy Certification, Restricted Categories, and What Actually Runs

Google Ads requires certifications for some healthcare categories, outright prohibits others, and enforces specific claim restrictions across all of them. Here's what the policy actually says and how to structure Google Ads campaigns that clear review and convert reliably.

10 min
Read
Tactical playbook

How to Respond to an FDA Warning Letter: The Step-by-Step Playbook for the First 15 Business Days

The first 15 business days after a warning letter determine how enforcement proceeds. Here's the exact sequence of actions - from calling an attorney in the first hour to submitting the formal response - that protects your practice and maximizes the chance of favorable resolution.

12 min
Read
Tactical playbook

How to Audit Your Healthcare Practice's Social Media for FDA/FTC Compliance: A Step-by-Step Framework

Your social media is the highest-velocity compliance surface in your practice - and the one that typically has the least review before publish. Here's the audit framework to catch compliance issues before a regulator does.

11 min
Read
Specialty playbook

Exosome Marketing Compliance: The Current FTC Enforcement Priority - and How to Stay Off the Target List

Exosome marketing sits at the top of the FTC's 2024-2026 healthcare enforcement priority list. The claim patterns they target are consistent - and fixable. Here's the full playbook.

9 min
Read
Specialty playbook

PRP Injection Marketing Compliance: What Orthopedics, Sports Medicine, and Hair Restoration Practices Keep Getting Wrong

PRP marketing looks simpler than stem cell marketing but carries a distinct compliance pattern. Here's what orthopedic, sports medicine, hair restoration, and aesthetic practices need to know about marketing PRP compliantly.

9 min
Read
Specialty playbook

Body Contouring Marketing Compliance: CoolSculpting, EmSculpt, Morpheus8 and the Device-Specific Rules Practices Miss

Body contouring devices have specific FDA-cleared indications. Marketing them for unapproved body areas, with guaranteed results, or with transformation-style before/afters triggers multiple enforcement patterns. Here's how to market compliantly.

10 min
Read
Specialty playbook

Hormone Replacement Therapy Marketing Compliance: HRT, TRT, and Bioidentical Advertising Rules

HRT, TRT, and bioidentical hormone marketing sits in an unusually complex regulatory position - prescription drugs plus compounded drugs plus anti-aging claim rules. Here's how to market these services compliantly.

10 min
Read

Stay ahead of enforcement

Scan your marketing before regulators do.

RegenCompliance checks every word of your clinic's marketing against live FDA and FTC enforcement data - and rewrites violations automatically.